Here, we demonstrated in vitro and in vivo the therapeutic potential of IL-15 armored CD70-CAR NK cells to eliminate both CD70+ tumor cells and, most interestingly, also tumor-promoting CD70+ CAFs in CRC and PDAC. Here, IL15 is linked to neoplasm.